Does myo-inositol oxygenase, the only enzyme to catalyze myo-inositol in vivo, play a role in the etiology of polycystic ovarian syndrome?

References

• Fauser BCJM. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25.
   Web of Science ®Google Scholar
• Facchinetti F, Bizzarri M, Benvenga S, et al. Results from the international consensus conference on myo-inositol and d-chiro-inositol in obstetrics and gynecology: the link between metabolic syndrome and PCOS. Eur J Obstet Gynecol Reprod Biol 2015;195:72–6.
   PubMed Web of Science ®Google Scholar
• Croze ML, Soulage CO. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie 2013;95:1811–27.
   PubMed Web of Science ®Google Scholar
• Arner RJ, Prabhu KS, Reddy CC. Molecular cloning, expression, and characterization of myo-inositol oxygenase from mouse, rat, and human kidney. Biochem Biophys Res Commun 2004;324:1386–92.
   PubMed Web of Science ®Google Scholar
• Papaleo E, Unfer V, Baillargeon J-P, et al. Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecol Endocrinol 2007;23:700–3.
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Lanzoni C, Ricchieri F, et al. Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecol Endocrinol 2008;24:139–44.
   PubMed Web of Science ®Google Scholar
• Costantino D, Minozzi G, Minozzi E, et al. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. Eur Rev Med Pharmacol Sci 2009;13:105–10.
   PubMed Web of Science ®Google Scholar
• Papaleo E, Unfer V, Baillargeon JP, et al. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertil Steril 2009;91:1750–4.
   PubMed Web of Science ®Google Scholar
• Gerli S, Papaleo E, Ferrari A, et al. Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS. Eur Rev Med Pharmacol Sci 2007;11:347–54.
   PubMed Web of Science ®Google Scholar
• Unfer V, Carlomagno G, Dante G, et al. Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecol Endocrinol 2012;28:509–15.
   PubMed Web of Science ®Google Scholar
• Baillargeon JP, Diamanti-Kandarakis E, Ostlund RE, et al. Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome. Diabetes Care 2006;29:300–5.
   PubMed Web of Science ®Google Scholar
• Heimark D, McAllister J, Larner J. Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls. Endocr J 2014;61:111–17.
   PubMed Web of Science ®Google Scholar
• Unfer V, Carlomagno G, Papaleo E, et al. Hyperinsulinemia alters myoinositol to d -chiroinositol ratio in the follicular fluid of patients with PCOS. Reprod Sci 2014;21:854–8.
   PubMed Web of Science ®Google Scholar
• Dyck PJ, Minnerath SR, O’Brien PC. Nerve glucose, sorbitol, fructose, and myo-inositol at various times after feeding in streptozotocin-induced diabetes in rats. Mayo Clin Proc 1989;64:905–10.
   PubMed Web of Science ®Google Scholar
• Narayanan S. Aldose reductase and its inhibition in the control of diabetic complications. Ann Clin Lab Sci 1993;23:148–58.
   PubMed Web of Science ®Google Scholar
• Henry DN, Del Monte M, Greene DA, et al. Altered aldose reductase gene regulation in cultured human retinal pigment epithelial cells. J Clin Invest 1993;92:617–23.
   PubMed Web of Science ®Google Scholar
• Goode D, Lewis ME, Crabbe MJC. Accumulation of xylitol in the mammalian lens is related to glucuronate metabolism. FEBS Lett 1996;395:174–8.
   PubMed Web of Science ®Google Scholar
• Mechanisms underlying the abnormal inositol metabolisms in diabetes mellitus [thesis]. ResearchSpace@Auckland: The University of Auckland; 2011. Available from: http://researchspace.auckland.ac.nz.
   Google Scholar
• Tominaga T, Dutta RK, Joladarashi D, et al. Transcriptional and translational modulation of myo-inositol oxygenase (Miox) by fatty acids: Implications in renal tubular injury induced in obesity and diabetes. J Biol Chem 2016;291:1348–67.
   PubMed Web of Science ®Google Scholar
• Sun L, Dutta RK, Xie P, et al. Myo-inositol oxygenase overexpression accentuates generation of reactive oxygen species and exacerbates cellular injury following high glucose ambience: a new mechanism relevant to the pathogenesis of diabetic nephropathy. J Biol Chem 2016;291:5688–707.
   PubMed Web of Science ®Google Scholar
• Xie P, Sun L, Oates PJ, et al. Pathobiology of renal-specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: its implications in tubulointerstitial fibrosis. Am J Physiol Renal Physiol 2010; 298:F1393–404.
   PubMed Web of Science ®Google Scholar
• Yang Q, Dixit B, Wada J, et al. Identification of a renal-specific oxido-reductase in newborn diabetic mice. Proc Natl Acad Sci USA 2000;97:9896–901.
   PubMed Web of Science ®Google Scholar
• Nayak B, Xie P, Akagi S, et al. Modulation of renal-specific oxidoreductase/myo-inositol oxygenase by high-glucose ambience. Proc Natl Acad Sci USA 2005;102:17952–7.
   PubMed Web of Science ®Google Scholar
• Nayak B, Kondeti VK, Xie P, et al. Transcriptional and post-translational modulation of myo-inositol oxygenase by high glucose and related pathobiological stresses. J Biol Chem 2011;286:27594–611.
   PubMed Web of Science ®Google Scholar
• Arner RJ, Prabhu KS, Krishnan V, et al. Expression of myo-inositol oxygenase in tissues susceptible to diabetic complications. Biochem Biophys Res Commun 2006;339:816–20.
   PubMed Web of Science ®Google Scholar
• Prabhu KS, Arner RJ, Vunta H, et al. Up-regulation of human myo-inositol oxygenase by hyperosmotic stress in renal proximal tubular epithelial cells. J Biol Chem 2005;280:19895–901.
   PubMed Web of Science ®Google Scholar
• Yang B, Hodgkinson A, Millward BA, et al. Polymorphisms of myo-inositol oxygenase gene are associated with Type 1 diabetes mellitus. J Diabetes Complicat 2010;24:404–8.
   PubMed Web of Science ®Google Scholar